Skip to main content
Shaping Europe’s digital future logo

European '1+ Million Genomes' Initiative

The 1+ Million Genomes initiative has the potential to improve disease prevention, allow for more personalised treatments and provide new impactful research.

The '1+ Million Genomes' (1+MG) initiative brings together 22 EU countries, the UK and Norway with a goal to have at least 1 million sequenced genomes accessible in the EU by 2022.

What is the benefit for EU citizens?

Genomics has the potential to revolutionise healthcare in many ways. It could lead to the development of more targeted personalised medicines, therapies and interventions. It could also enable better diagnostics, boost prevention and make more efficient use of scarce resources. From cancer to rare diseases to neurodiseases and prevention, genomics can greatly improve health conditions of EU citizens.

Equally important, genomics has the potential to improve the effectiveness, accessibility, sustainability and resilience of health systems in the European Union.

What are the Signatories trying to achieve?

The Signatory countries have various objectives. Among these, are:

  • ensuring that appropriate technical infrastructure is available across the EU, allowing for secure, federated access to genomic data;
  • making sure that ethical and legal implications of genomics are clear and taken into account;
  • ensuring that the general public and policy makers in Member States and signatory countries are well informed about genomics, in order to ensure its uptake by healthcare systems and integration into personalised healthcare.

The EU as a global player in genomics

We live in an era where genomics becomes increasingly important globally. The European Union’s genomic collaboration and research have to be citizen-focused and patient-friendly. It should make sure that the highest standards are applied for the usage, access and storage of genomic data.

Implementation of the Declaration

Reaching at least 1 million sequenced genomes in the EU by 2022 is a collaborative task, which will involve a variety of stakeholders. These include health professionals, specialists, researchers, decision-makers, patient organisations and more.

The signatory countries had their kick-off meeting on 21 September 2018 in Brussels. Since then, they meet regularly with each other and in 11 specialised working groups to make sure that by 2022 there will be a research cohort of at least 1 million sequenced genomes accessible in the EU.

In late 2020, the Commission created a special expert group (1+MG Group) with a view to formalising and facilitating the cooperation and coordination at the level of national representatives of the signatory countries. The group is co-chaired by the Commission and an EU country representative.

The 1+MG Roadmap 2020-2022

To meet the target of having over 1 million genomes sequenced by the end of 2022, the signatories of the 1+ Million Genomes initiative adopted the '1+MG Roadmap 2020-2022' (.pdf). The Roadmap  provides a clear perspective for tangible outcomes over the course of the next three years.

The Horizon 2020 project 'Beyond 1 Million Genomes' (B1MG) supports and coordinates on the operational level the implementation of the Roadmap by leading up to an agreement on the infrastructure set-up, legal and technical guidance, and data standards and best practices to enable data access.

It will look beyond the initiative towards the development of a sustainable data sharing infrastructure. This will support clinicians to pursue personalised medicine, benefit patients, help scientists to form a better understanding of diseases, and innovators to contribute to and boost the European economy.

Genome of Europe

The Genome of Europe is a multi-country project designed and coordinated with the support of B1MG. It brings together European countries to build a high-quality European network of national genomic reference cohorts, representative of the European population. 

All countries involved generate via whole genome sequencing a national genomic reference dataset based on their own national population cohort, all according to jointly established ‘1+MG-proof’ guidelines. Each country’s dataset will form a unique national reference collection in its own right. The collection will benefit national personalised healthcare and prevention strategies.

Collectively, crosslinked via the 1+MG initiative, the national collections will establish a world-class European reference data resource (The Genome of Europe) for research and innovation of healthcare.

Background

The Declaration on genomics cooperation, 'towards access to at least 1 million sequenced genomes in the EU by 2022', was launched on Digital Day 2018 and is signed by 22 EU countries, the UK and Norway. The initiative is open to countries of the European Economic Area and the European Free Trade Association. It is part of the EU’s agenda for the Digital Transformation of Health and Care.

This cooperation mechanism is supported and facilitated by the European Commission, which works closely with the Member States in order to ensure that in 2022 there will be at least a cohort of 1 million sequenced genomes accessible for research and personalised medicine in the EU.

Latest

The EU Digital COVID Certificate: a global standard with more than 591 million certificates

Today, the Commission adopted a report on the EU Digital COVID Certificate and its implementation across the EU. The report shows that the EU certificate has been a crucial element in Europe's response to the COVID-19 pandemic, with more than 591 million certificates generated. The certificate, which covers COVID-19 vaccination, test and recovery, facilitates safe travel for citizens, and it has also been key to support Europe's hard-hit tourism industry. The EU Digital COVID Certificate is a success worldwide: it has set a global standard and is currently the only system already in operation at international level. 43 countries across four continents are plugged into the system, and more will follow over the coming weeks and months.

PRESS RELEASE |
Coronavirus: 200th EU disinfection robot delivered to European hospital, a further 100 confirmed

This week the Commission delivered the 200th disinfection robot – to Consorci Corporació Sanitària Parc Taulí hospital in Barcelona. The robots, donated by the Commission, help sanitise COVID-19 patient rooms and are part of the Commission's action to supply hospitals across the EU to help them cope with the effects of the coronavirus pandemic. Further to these initial 200 robots announced in November last year, the Commission secured the purchase an additional 100, bringing the total donations to 300.

PRESS RELEASE |
EU Digital COVID Certificate enters into application in the EU

As of the 1st of July, the EU Digital COVID Certificate Regulation entered into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across the EU.

PRESS RELEASE |
Coronavirus: 100th EU disinfection robot delivered to European hospitals

On 28 June the 100th disinfection robot was delivered, part of the Commission's action to supply these to hospitals across the EU to help them cope with the effects of the coronavirus pandemic. Emergency Clinical Hospital Bagdasar-Arseni in Bucharest is receiving the robot today and six other hospitals in Romania are set to have one delivered in the coming days, thus benefitting from these robots' ability to disinfect a standard size patient room in as quickly as 15 minutes by using ultraviolet light.

Related Content

Big Picture

eHealth

The European Commission is working to provide citizens with access to safe and top quality digital services in health and care.

Dig deeper

See Also

Managing health data

The European Commission adopted a Communication and a Staff Working Document on Digital transformation of health and care to boost European Union action.

eHealth experts

The European Commission created two expert groups working on eHealth: the eHealth Stakeholder Group and a temporary eHealth Task Force.